Mural Oncology to Host First Virtual Investor Day on September 26, 2024

a week ago

Company will provide clinical overview and update on late-stage clinical candidate, nemvaleukin alfa, and overview of IL-18 pipeline program ...

Ticker	Sentiment	Impact
MURA	Neutral	14 %